| abstract |
Bruton tyrosine kinase (Btk) kinase inhibitor combinations are provided, for example, 1 - ((R) -3- (4-amino-3- (4-phenoxyphenyl) -1H-pyrazolo [3,4-d] pyrimidin -1-yl) piperidin-1-yl) prop-2-en-1-a, with a second anticancer agent. Methods for treating cancers and autoimmune disorders are also provided by administering combinations of Bruton tyrosine kinase inhibitors (Btk), for example, 1- ((R) -3- (4-amino-3- (4-phenoxyphenyl) -1H-pyrazolo [3,4-d] pyrimidin-1-yl) piperidin-1-yl) prop-2-en-1-a, and second anticancer agents. |